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1Introduction
International cancer organizations recommend the use of 
comprehensive geriatric assessment (CGA) for optimizing 
treatment plans of older patients with cancer (1-3). However, 
despite this recommendation, consensus regarding the ideal 
CGA model in geriatric oncology has not been formulated. 
Published data suggest that optimal effect of CGA requires 
activities in three steps (4, 5). First, a multidimensional, 
interdisciplinary patient evaluation is required to identify 
the general health status. This includes medical, functional, 
cognitive, social, nutritional and psychological parameters 
(6). Since this method is time-consuming, several short 
screening tools have been developed and compared in order 
to optimally identify patients who don’t need a geriatric 
assessment (GA) (7). Second, identified problems should 
trigger interdisciplinary care planning, which comprises 
recommending geriatric interventions and selecting the most 
appropriate cancer treatment. Organizing multidisciplinary 
team meetings (MDTMs) - a forum for multidisciplinary 
cancer teams to regularly convene and discuss the diagnosis 
and treatment of patients (8)- or integrating geriatricians or 
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Abstract: Objectives: The aim of this study is to describe a large-scale, Belgian implementation project about 
geriatric assessment (=GA) in daily oncology practice and to identify barriers and facilitators for implementing 
GA in this setting. Design / setting / participants: The principal investigator of every participating hospital 
(n=22) was invited to complete a newly developed questionnaire with closed- and open-ended questions. The 
closed-ended questions surveyed how GA was implemented. The open-ended questions identified barriers and 
facilitators for the implementation of GA in daily oncology practice. Descriptive statistics and conventional 
content analysis were performed as appropriate. Results: Qualifying criteria (e.g. disease status and cancer type) 
for GA varied substantially between hospitals. Thirteen hospitals (59.1%) succeeded to screen more than half 
of eligible patients. Most hospitals reported that GA data and follow-up data had been collected in almost all 
screened patients. Implementing geriatric recommendations and formulating new geriatric recommendations 
at the time of follow-up are important opportunities for improvement. The majority of identified barriers were 
organizational, with high workload, lack of time or financial/staffing problems as most cited. The most cited 
facilitators were all related to collaboration. Conclusion: Interventions to improve the implementation of GA in 
older patients with cancer need to address a wide range of factors, with organization and collaboration as key 
elements. All stakeholders, seeking to improve the implementation of GA in older patients with cancer, should 
consider and address the identified barriers and facilitators.
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healthcare professionals with specific geriatric experience 
can be valuable for setting priorities in agreement with the 
patient (9). In Belgium, a MDTM in oncology is called a 
MOC (Multidisciplinary Oncological Consult; in Dutch: 
Multidisciplinair Oncologisch Consult (MOC); in French: 
Consultation Oncologique Multidisciplinaire (COM)). Third, 
treatment plans need to be implemented. Since the majority 
of older patients with cancer receive ambulatory care, there 
is a need for continuity of care across several settings. Patient 
follow-up is essential to monitor and adjust treatment plans.
Recent literature reviews in geriatric oncology report 
that geriatric screening and assessment detect impairments 
not identified in routine history and physical examination, 
influence treatment decision making and predict treatment 
tolerability and overall survival in groups of homogeneous and 
heterogeneous cancer diagnoses (3, 10). The implementation 
of CGA in oncology has not yet focused much on 
multidisciplinary care planning or continuity of care. Therefore, 
the term ‘GA’ (geriatric assessment) has been preferred above 
CGA for this approach in older patients with cancer (3). In 
order to create a ‘CGA’ in geriatric oncology, researchers 
should broaden the scope beyond geriatric screening and 
assessment. However, these studies are only feasible if geriatric 
screening and assessment is incorporated in daily oncology 
practice -an exercise that may not be underestimated, since 
the gap between evidence based practice and clinical care is 
one of the most consistent findings in health services research 
(11). So, studies on implementation of GA in daily oncology 
practice are urgently required. A recent survey, focusing on 
treating physician’s general experiences and expectations 
according to the implementation of GA in 9 Belgian hospitals, 
identified for example that improving availability of GA results 
at the moment of treatment decision making is a challenge 
(9). That study also introduced a generic term for the medical 
or paramedical graduate(s) appointed to coordinate the 
performance of a GA, namely a ‘trained healthcare worker’ 
(THCW) (9).
The Cancer Plan -an initiative from the Belgian, federal 
government in which improving geriatric oncology care is 
one of the 30 aims- supports among others a multicenter 
project (n=22) for tailored implementation of a uniform 
GA in daily oncology practice (2012-2015). Consequently, 
participating hospitals are free to specify to what extent project 
implementation is feasible considering available resources. The 
GA process of this implementation project comprises detection 
of eligible patients aged 70 or older, use of a geriatric screening 
tool (G8) (7, 12, 13) followed by GA if necessary and patient 
follow-up with repeat GA ten to 14 weeks after the initial 
assessment. In brief, the GA includes social data, functional 
status, fall history in the past 12 months, fatigue, pain, quality 
of life, cognitive status, mental status and nutritional status. 
Based on the GA results geriatric recommendations are 
communicated. The follow-up is conducted to evaluate the 
performance of these geriatric recommendations. Additionally, 
geriatric recommendations that need to be reconsidered or new 
geriatric recommendations, can be defined. 
This study describes the evaluation of the performance of 
the project mentioned above. The main objective is to describe 
the implementation of GA in daily oncology practice and to 
identify barriers and facilitators for implementing GA in this 
setting.
Methods
Study design
A cross-sectional survey design was used. Data were 
collected in May and June 2013 (8 months after onset of the 
3-year project).
Participants
The principal investigator (PI) of every hospital 
participating in the multicenter GA implementation project, 
including 8 academic and 14 non-academic hospitals, was 
asked to complete a questionnaire (n=22). The PI of each 
centre was the person who was dedicated to coordinate the 
GA implementation project. This person could be a medical 
oncologist, geriatrician or a THCW. 
Questionnaire
First, the content of the questionnaire from a previous 
Belgian geriatric oncology care survey (9), was modified 
in a new one appropriate for the current context. Next, the 
Dutch questionnaire was translated in French. Finally, face and 
content validity of the questionnaire were assessed by an expert 
panel. 
The final questionnaire (available upon request) comprised 
three parts. The first part included general information about 
the hospital (e.g. region; character (i.e. academic or non-
academic); number of beds and geriatric beds; number of 
geriatricians, medical oncologists, hematologists, radiation-
oncologists; number of total admissions, admissions of patients 
aged 70 or older in the hospital and on geriatric and non-
geriatric wards, newly detected cancer cases per year, newly 
detected cancer cases per year in patients aged 70 or older; and 
number of MDTMs).
The second part included 37 questions in 2 categories. 
The first category is a bundling of questions to identify local 
working methods concerning 6 topics (geriatric screening and 
assessment (n=9), geriatric recommendations (n=4), MDTM 
(n=5), follow-up (n=3), aspects of duration (n=3) and aspects 
of communication (n=3)). The second category used response 
categories (0-10%/11-20%/21-40%/41-60%/61-80%/81-100%) 
to survey the estimated percentage of patients in whom a 
specific step of the GA process was conducted (n=10). 
The third part of the questionnaire comprised of two open-
ended questions: “What are the three most important barriers/
facilitators for the implementation of GA in your hospital?” 
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Data collection
Paper and electronic versions of the questionnaire were sent 
to the PI’s. These persons received several electronic reminders 
to complete the questionnaire.
Data analysis
Quantitative data were analyzed using SPSS version 16.0. 
Descriptive statistics (frequencies, percentages, modes, 
medians, means, ranges and standard deviations) were 
calculated as appropriate. 
Answers to the two open-ended questions were analyzed 
using conventional content analysis. This approach helps 
researchers to gain a better understanding of a phenomenon 
by deriving codes from data during data analysis (14). PH and 
CK, the first two authors, separately created two preliminary 
lists of codes after several readings of the data. These lists 
were compared. Discrepancies were resolved by iterative 
discussions until consensus was obtained. Irrelevant answers 
and answers with multiple barriers or facilitators were 
discussed, as well. In case of the latter, the response was coded 
into multiple categories. During the coding process, codes were 
aggregated into themes which were further grouped into three 
response categories (knowledge, attitudes and organizational 
characteristics).
Ethical considerations
The Ethical Committee of the University Hospitals Leuven 
reviewed and approved the multicenter GA implementation 
project in older patients with cancer, of which this study 
is a part. This survey was considered to have no ethical 
implications, as participation was voluntary and required no 
individual patient data.
Results
Sample Characteristics
All questionnaires were completed and returned by the 
PI’s (response rate=100%). The main characteristics of the 
participating hospitals are described in table 1. Of all patients 
yearly admitted to these 22 hospitals, 24.3% was at least 
70 years old. On annual basis, 7.7% of these patients were 
confronted with a new diagnosis of cancer. These accounted 
for 41.8% of all new detected cancer cases per year in the 
participating hospitals.
Practical aspects of GA implementation
Most hospitals (54.5%) opted to conduct geriatric screening 
and assessment in all new cancer cases and all patients with 
progressive disease or relapse. Sometimes geriatric screening 
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Table 1
Characteristics of Belgian hospitals participating in a GA implementation project
Characteristics of participating hospitals  (n= 22) n (%) M ± SD (min-max)
Region 
  - Flanders 11 (50.0) /
  - Wallonia 6 (27.3) /
  - Brussels, capitol region 5 (22.7) /
Character
  - Academic 8 (36.4) /
  - Non-academic 14 (63.6) /
Number of beds / 767.2 ± 484.8 (154-2500)
Number of beds on a geriatric ward (n=20) / 72.8 ± 39.3 (0-135)
Number of geriatricians / 3.0 ± 1.7 (0-6)
Number of medical oncologists / 4.7 ± 3.8 (1-17)
Number of hematologists / 3.8 ± 3.5 (1-16)
Number of radiation-oncologists / 5.1 ± 4.2 (0-19)
Number of all patients admitted to the hospital*  (n=21) / 32461.8 ± 25770.3 (9005-130704)
Number of patients admitted to the hospital aged 70 years or older* (n=20) / 7891.4 ± 3511.9 (2764-16314)
  - On geriatric wards (n=17) / 1346.5 ± 736.0 (146-3041)
  - On non-geriatric wards (n=20) / 6746.9 ± 3112.5 (1912-14171)
Number of all new detected cancer cases in the hospital* (n=19) / 1460.3 ± 828.2 (430-4216)
Number of new detected cancer cases in patients aged 70 or older in the hospital* (n=18) / 610.8 ± 310.9 (181-1339)
Number of all MDTMs in the hospital* / 2041.5 ± 1509.0 (309-7128)
Legend: M = mean; SD = standard deviation; min = minimum; max = maximum; MDTM = multidisciplinary team meeting; * = numbers of the year 2011 (n = 2), 2012 (n = 17), 2011 
and 2012 (n=1) or year not specified (n = 2).
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Table 2
Geriatric screening and assessment in the participating hospitals (n = 22)
Questions n (%)
GERIATRIC SCREENING AND ASSESSMENT
What is the qualifying disease status for geriatric screening and assessment in the treatment decision making process?
  - All new cancer cases, except for patients with progressive disease or relapse 0 (0.0)
  - All new cancer cases and all patients with progressive disease or relapse 12 (54.5)
  - All new cancer cases and preselected patients with progressive disease or relapse 6 (27.3)
  - Preselected patients only 4 (18.2)
Is geriatric screening and assessment applied in specific tumor types only?
  - No 17 (77.3)
  - Yes 5 (22.7)
Where is the geriatric screening completed?*
  - Home 1 (4.5)
  - Inpatient hospital ward 22 (100.0)
  - Consultation 16 (72.7)
  - Radiation therapy ward 6 (27.3)
  - Oncological day clinic 12 (54.5)
  - Geriatric day clinic 6 (27.3)
  - Other 2 (9.1)
Where is the geriatric assessment completed?*
  - Inpatient hospital ward 22 (100.0)
  - Consultation 16 (72.7)
  - Radiation therapy ward 6 (27.3)
  - Oncological day clinic 11 (50.0)
  - Geriatric day clinic 9 (40.9)
  - Other 0 (0.0)
What method(s) is/are used to complete a geriatric assessment?*
  - Interview 22 (100.0)
  - Observation 10 (45.5)
  - Self-report 7 (31.8)
  - Other 3 (13.6)
How many methods are used to complete a geriatric assessment?
  - 1 10 (45.5)
  - 2 5 (22.7)
  - 3 6 (27.3)
  - 4 1 (4.5)
GERIATRIC RECOMMENDATIONS
How are geriatric recommendations made/generated?*
  - Case review between the THCW and the geriatrician (no face to face contact between geriatrician and patient) 9 (40.9)
  - Case review by the geriatrician (face to face contact with the patient) 10 (45.5)
  - Case review between the THCW and the internal geriatric liaison team 10 (45.5)
  - Case review on the MDTM 8 (36.4)
  - Case review between the THCW and the treating physician 11 (50.0)
  - Referral and case review on geriatric day clinic 5 (22.7)
  - Geriatric guidelines/procedures 6 (27.3)
  - Other 2 (9.1)
How many geriatric recommendations are on average given to a patient?
  - 1 geriatric recommendation 4 (18.2)
  - 2 geriatric recommendations 8 (36.8)
  - 3 geriatric recommendations 9 (40.9)
  - 4 geriatric recommendations 1 (4.5)
  - 5 geriatric recommendations or more 0 (0.0)
and assessment were applied in specific tumor types only due 
to organizational reasons (eg. time, staffing,…). Geriatric 
screening and assessment were conducted in all kinds of 
locations with the inpatient hospital ward as the most cited 
place (100%). All hospitals used interviews to collect GA 
data. Twelve hospitals (54.5%) used other methods (e.g. 
observation, self-report) as well. Geriatric recommendations 
for interventions are mainly made through case review. Several 
combinations of healthcare workers were common for case 
review: THCW and geriatrician (without face-to-face contact 
between geriatrician and patient) (40.9 %), geriatrician only 
(with face-to-face contact between geriatrician and patient) 
(45.5 %), THCW and internal geriatric consultation team 
(45.5%), THCW and treating physician (50.0 %). The 
treating physician could be the medical oncologist, radiation-
oncologist, hematologist, surgeon,… A patient received on 
average two geriatric recommendations. Mostly, verification 
of the patient chart was used to evaluate compliance with 
these recommendations (81.8%). All hospitals summarized 
MDTMs in a report, which was often directly sent to the 
general practitioner (81.8%). Both face-to-face contact (90.9 
%) and telephone calls (81.8 %) were used to conduct follow-
up of the patient. Usually this was a GA without geriatric 
screening. Detailed information on GA implementation can be 
found in table 2. 
Table 3 shows that implementation of GA in oncology 
practice is a matter of both the oncology and the geriatric 
department. More than half of hospitals managed to involve 
both departments in one or more GA steps. Conducting a 
GA (63.6%) and making GA results (77.3%) and geriatric 
recommendations (59.1%) available for healthcare 
professionals were steps in the GA process, feasible within 24 
hours after each previous step. Most hospitals used at least 2 
media to communicate screening results (63.6%), GA results 
(77.3%) and geriatric recommendations (86.4%) with the 
electronic report being the most frequently used (81.8-90.9%). 
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What method is used to evaluate the implementation of given geriatric recommendations?*
  - Verification of the patient chart 18 (81.8)
  - Contact with the treating physician 5 (22.7)
  - Contact with the patient 12 (54.5)
  - Contact with other healthcare professionals (employed in the hospital) 13 (59.1)
  - Contact with the general practitioner 4 (18.2)
  - Other 3 (13.6)
MULTIDISCIPLINARY TEAM MEETING
Is the MDTM summarized in a MDTM report?
  - No 0 (0.0)
  - Yes 22 (100.0)
Does the geriatrician receive the MDTM report?
  - No 18 (81.8)
  - Yes 4 (18.2)
Does the general practitioner receive the MDTM report?
  - No 4 (18.2)
  - Yes 18 (81.8)
Do the involved healthcare professionals organize a MDTM for older cancer patients only?
  - No 18 (81.8)
  - Yes: how frequent is a MDTM specifically for older cancer patients organized? 4 (18.2)
    o On demand 0
    o Every week 4 (100.0)
    o Once every two weeks 0
    o Other 0
FOLLOW-UP
What method is used to conduct the follow-up?*
  - Face to face contact 20 (90.9)
  - Telephone 18 (81.8)
  - E-mail 7 (31.8)
  - Other 0 (0.0)
What is the content of the follow-up?**
  - Geriatric screening only 0 (0.0)
  - Geriatric screening and geriatric assessment if necessary 3 (14.2)
  - Geriatric assessment without geriatric screening 16 (76.2)
  - Other 2 (9.5)
Legend: THCW = trained healthcare worker; MDTM = multidisciplinary team meeting; * = multiple answers possible; ** = data of 1 hospital missing, results calculated on n=21; The 
number in bold indicates the median or mode when appropriate. The median describes the central tendency of ordinal data. The mode describes the central tendency of nominal data.
Table 4 provides detailed information on aspects related to GA 
duration and communication.
Implementation of GA 
Seven (31.8%) and 6 (27.3%) participating hospitals 
reported that geriatric screening was conducted in 
approximately half (41-60%) and a majority (61-80%) of 
patients eligible for GA, respectively. Eighteen (81.8%) 
hospitals stated that a GA is conducted in almost all 
patients (81-100%) at risk according to the result of 
the geriatric screening tool (G8). Almost three out of four 
hospitals established to define geriatric recommendations 
for interventions for a majority of patients (61-100%) after 
performing a GA. Only 6 hospitals (27.2%) reported that 
the majority (61-100%) of geriatric recommendations for 
interventions were implemented. All percentages related 
to MDTMs (availability of GA results during MDTM, 
presence of someone with specific oncology and geriatric 
knowledge during MDTM, description of GA results/geriatric 
recommendations in MDTM report) were poor (mainly ranging 
from 0-40%). Eighteen (81.8%) hospitals stated that follow-up 
was completed in almost all patients (81-100%). Sixty percent 
of hospitals reported that new geriatric recommendations were 
hardly ever (0-10%) formulated at the time of follow-up. 
Detailed results concerning implementation-related aspects can 
be consulted in table 5.
Facilitators and barriers
The 22 PI’s wrote down 62 barriers and 56 facilitators. 
The majority of identified barriers for implementing GA in 
daily oncology practice were organizational characteristics 
(53%), with high workload, lack of time or financial/staffing 
problems (n=18) most frequently mentioned. The facilitators 
most often reported were all related to collaboration (66%): (i) 
appreciation of the relevance of the GA process by all persons 
involved (n=9), (ii) embedding GA for cancer patients in other 
geriatric care structures (e.g. internal geriatric liaison, geriatric 
day clinic) (n=8), (iii) motivation or interest among healthcare 
professionals involved (n=6). Approximately one out of four 
barriers was related to collaboration, as well. Results of the 
qualitative analysis can be consulted in table 6 (barriers) and 7 
(facilitators).
Discussion
International cancer organizations promote the systematic 
implementation of (C)GA in daily oncology practice 
(1-3). However, implementing guidelines into practice is a 
known problem (11). Therefore, implementation studies are 
necessary. This survey describes the evaluation of a Belgian 
multicenter project for implementation of a uniform GA in 
daily oncology practice, including a qualitative analysis of 
important facilitators and barriers regarding the topic. Detailed 
information regarding the implementation process which 
is center-specific, is not described in this article since the 
implementation study is still ongoing.  
Tailored implementation was used to move the uniform GA 
into practice. Consequently, participating hospitals were free 
to specify to what extent project implementation was feasible 
considering available resources. Despite a previous survey 
and a recent international report recommending GA in all 
older patients with cancer (new cancer cases and all patients 
with progressive disease or relapse) (3, 9), several hospitals 
participating in the multicenter GA implementation project 
used a preselection based on tumor type and/or disease status as 
qualifying criteria. Reducing the target population at inclusion 
might be an efficient strategy to guarantee feasibility, but 
excludes patients who might benefit as well. However, despite 
this freedom, 9 hospitals (40.9%) failed to conduct a geriatric 
screening in more than half of eligible patients. This could be 
related to the workload of the THCW, since this person usually 
is responsible for conducting screening and/or the GA –a time 
consuming task necessary in the majority of patients (81.8%) 
according to screening results. Assigning the screening task to 
treating physicians or nurses might be a possible solution for 
increasing the screening percentage.
The average number of geriatric recommendations 
per patient was 2. This complies with the study of Allen et 
al. on effectiveness of geriatric consultation teams, telling 
that limiting and prioritizing the number of geriatric 
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Table 3
Affiliations of healthcare professionals involved in GA in the participating hospitals (n = 22)
Elements of GA based 
treatment decision making
AFFILIATIONS, n (%)
ONCOLOGY GERIATRICSS GERIATRICS* IGL GDC
Screening 19 (86.4) 15 (68.2) 10 (45.5) 11 (50.0) 7 (31.9)
GA 16 (72.7) 15 (68.2) 9 (40.9) 12 (54.5) 6 (27.3)
Geriatric recommendations 20 (90.1) 13 (59.1) 9 (40.9) 10 (45.5) 6 (27.3)
Follow-up** 17 (81.0) 12 (57.1) 7 (33.3) 7 (33.3) 3 (14.3)
Legend: GA = geriatric assessment; IGL = internal geriatric liaison; GDC = geriatric day clinic; GERIATRICSS = Geriatric department with GDC and IGL; GERIATRICS* = Geriatric 
department with exclusion of GDC and IGL; ** = data of 1 hospital missing, results calculated on n = 21
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Table 4
GA implementation aspects in the participating hospitals (n = 22)
n (%)
DURATION Same day 1 day 2 days 3 days ≥4 days NA
− How many days does it take for a GA to be conducted after a geriatric 
screening?
13 (59.1) 1 (4.5) 2 (9.1) 2 (9.1) 4 (18.2) 0 (0.0)
− How many days does it take for GA results to be available after a GA? 9 (40.9) 8 (36.4) 3 (13.6) 2 (9.1) 0 (0.0) 0 (0.0)
− How many days does it take for GA recommendations to be available after a 
GA?
10 (45.5) 3 (13.6) 4 (18.2) 4 (18.2) 1 (4.5) 0 (0.0)
COMMUNICATION Paper report Electronic 
report
Phone Face to face 
contact
E-mail Other
− What medium is used to communicate geriatric screening results to the 
treating physician?
5 (22.7) 18 (81.8) 7 (31.8) 12 (54.5) 5 (22.7) 1 (4.5)
− What medium is used to communicate GA results to the treating physician? 5 (22.7) 20 (90.9) 8 (36.4) 13 (59.1) 6 (27.3) 2 (9.1)
− What medium is used to communicate geriatric recommendations to the 
treating physician?
4 (18.2) 20 (90.9) 10 (45.5) 15 (68.2) 7 (31.8) 2 (9.1)
NUMBER OF COMMUNICATION MEDIA 0 1 2 3 4 5
− Geriatric screening results 0 (0.0) 8 (36.4) 7 (31.8) 3 (13.6) 3 (13.6) 1 (4.5)
− GA results 0 (0.0) 5 (22.7) 8 (36.4) 3 (13.6) 6 (27.3) 0 (0.0)
− Geriatric recommendations 0 (0.0) 3 (13.6) 10 (45.5) 2 (9.1) 6 (27.3 1 (4.5)
Legend: GA = geriatric assessment; NA = not applicable; The number in bold indicates the mean or mode when appropriate. The mode describes the central tendency of nominal data. 
The mean describes the central tendency of ratio data. 
Table 5
Estimated percentages related to the implementation of GA in the participating hospitals (n = 22)
 n (%)
Estimated percentage of… 0-10% 11-20% 21-40% 41-60% 61-80% 81-100%
- Patients, eligible for GA, in whom a geriatric scree-
ning is conducted
2 (9.1) 4 (18.2) 3 (13.6) 7 (31.8) 6 (27.3) 0 (0.0)
- Patients in whom a GA is conducted if necessary 
according to geriatric screening
1 (4.5) 0 (0.0) 0 (0.0) 1 (4.5) 2 (9.1) 18 (81.8)
- Patients in whom geriatric recommendations are 
given after geriatric screening and GA
2 (9.1) 0 (0.0) 2 (9.1) 2 (9.1) 6 (27.3) 10 (45.5)
- Geriatric  recommendations that are implemented 0 (0.0) 2 (9.1) 6 (27.3) 8 (36.4) 3 (13.6) 3 (13.6)
- Patients of whom geriatric screening and GA 
results are available during a MDTM
5 (22.7) 6 (27.3) 3 (13.6) 2 (9.1) 4 (18.2) 2(9.1)
- MDTMs with at least one attendee with specific 
experience in the field of oncology and geriatrics
7 (31.8) 4 (18.2) 5 (22.7) 3 (13.6) 2 (9.1) 1 (4.5)
- MDTM reports in which the GA results and/or GA 
recommendations  are described
14 (63.7) 3 (13.6) 1 (4.5) 2 (9.1) 2 (9.1) 0 (0.0)
- GA results and/or recommendations that are com-
municated to the general practitioner
8 (36.4) 1 (4.5) 4 (18.2) 1 (4.5) 2 (9.1) 6 (27.3)
- Patients with a systematic follow-up after a geria-
tric screening or GA
1 (4.5) 1 (4.5) 0 (0.0) 2 (9.1) 18 (81.8)
- Patients in whom new geriatric recommendations 
are formulated at the time of follow-up*
12 (60.0) 6 (30.0) 1 (5.0) 0 (0.0) 0 (0.0) 1 (5.0)
Legend: GA = geriatric assessment; MDTM = multidisciplinary team meeting; * = data of 2 hospitals missing, results calculated on n=20; The number in bold indicates the median. The 
median describes the central tendency of ordinal data.  In case of two possible medians, the bold ciphers are underlined, as well.
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Table 6
Barriers for implementation of GA in daily oncology practice
BARRIERS
Response category Code Description of category n (n=62)*
KNOWLEDGE
Geriatric care Lack of familiarity with geriatric care 2
ATTITUDES
Consensus concerning the project
• Evidence base The evidence base for geriatric screening and assessment is 
discussable
2
• Accuracy and validity of GA data Accuracy and validity of GA data are discussable 3
• Selection bias GA implementation is hindered by possible selection bias 1
Collaboration
• Relevance GA implementation is hindered if relevance of the concept is 
not appreciated by all involved persons
3
• Motivation or interest  Lack of motivation or interest with involved healthcare 
professionals
5
• Image of geriatric care Unfavorable image of geriatric care hinders collaboration 2
• Planning difficulties GA implementation is impeded by planning difficulties when 
there is a short time period between diagnosis and onset of 
therapy
2
Collaboration concerning a specific GA 
step
• Screening Lack of collaboration for completing a screening 2
• Recommendations Lack of collaboration for giving geriatric recommendations 1
• Referrals Lack of collaboration to refer patients 1
Communication
• Dialogue Lack of dialogue between involved healthcare professionals 3
• Patient chart GA results and/or recommendations are not reported in the 
patient chart or these data are not (easily) accessible
2
ORGANIZATIONAL CHARACTERISTICS
Geriatric care program Absence of geriatric care program impedes GA implementa-
tion in the oncology setting
1
MDTM GA implementation is hindered when MDTMs are not opti-
mally organized
4
Time/staffing/workload/finances GA implementation is impeded by high workload or lack of 
time, finances and/or staffing
18
Site count Perception that implementation of GA is impeded when a 
hospital counts several sites
3
Accommodation GA implementation is hindered by inappropriate accommo-
dation
1
Staff turnover Belief that high staff turnover within involved healthcare 
professionals impedes GA implementation
2
Detection of eligible patients Lack of a user-friendly method to detect eligible patients 4
Legend: GA = geriatric assessment; THCW = trained healthcare worker; MDTM = multidisciplinary team meeting; * = total number of described barriers
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recommendations positively affects compliance to geriatric 
recommendations (15). These were often generated using case 
review. However, the composition of the ideal case review 
cannot be determined, probably because this depends on local 
preferences and resources. Giving geriatric recommendations 
is a high ranked focus of the current project, but data on giving 
and implementing geriatric recommendations show that these 
aspects need optimization (e.g. 4 hospitals (18.2%) reported to 
give geriatric recommendations in less than half of evaluated 
patients and 8 hospitals (36.4%) reported that less than half of 
given geriatric recommendations were implemented). This also 
applies to integration of GA results in the MDTM. Whereas 
several studies have shown that GA data influence treatment 
decision making in older patients with cancer (3, 10, 16, 17), 14 
PI’s (63.6%) reported that during a MDTM geriatric screening 
and/or GA results were often unavailable. This might be linked 
to the lack of clinical guidelines for GA based modifications 
of cancer treatments (18). However, although this project 
Table 7
Facilitators for implementation of GA in daily oncology practice
FACILITATORS
Response category Code Description of category n (n=56)*
KNOWLEDGE
Geriatric care GA implementation is facilitated when involved healthcare professionals 
are familiar with geriatric care
2
ATTITUDES
Consensus concerning the 
project
GA implementation is encouraged when involved healthcare professio-
nals consent with the project
2
Collaboration
• Relevance GA implementation is facilitated when relevance of the concept is appre-
ciated by all involved persons
9
• Motivation or interest Motivation or interest with healthcare professionals concerning GA 
supports its implementation
6
• Optimal multidisciplinary 
collaboration
GA implementation in facilitated when multidisciplinary collaboration is 
optimally organized
5
• Oncological care structures GA implementation is facilitated when the project is embedded in other 
oncological care structures (e.g. oncological clinical nurse specialist)
4
• Geriatric care structures GA implementation is facilitated when the project is embedded in other 
geriatric care structures (e.g. internal liaison team, geriatric day clinic)
8
• Organizational support GA implementation is supported by several organizational levels (e.g. 
middle management, board of directors)
3
Collaboration concerning a 
specific GA step
• Screening Patients are spontaneously referred for geriatric screening 2
Communication
• Dialogue Constructive dialogue between healthcare professionals facilitates GA 
implementation
1
ORGANIZATIONAL CHARACTERISTICS
THCW GA implementation is promoted when THCWs are appointed to coordi-
nate the project
4
Geriatric care program Presence of a geriatric care program facilitates GA implementation 3
MDTM GA implementation is facilitated when MDTMs are optimally organized 5
Budget/finances Availability of a project fund for financing on site implementation encou-
rages GA implementation
1
Information technology 
resources
Implementation is facilitated when patient charts are electronic 1
Legend: GA = geriatric assessment; THCW = trained healthcare worker; MDTM = multidisciplinary team meeting; * = total number of described facilitators
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mainly focuses on the systematic implementation of geriatric 
screening and assessment, these data indicate that it is possible 
to successfully implement more advanced GA steps at the same 
time as well (10 hospitals gave geriatric recommendations 
in 81-100% of patients, 3 hospitals reported that 81-100% of 
recommendations were implemented and 2 hospitals stated 
that GA data were available for 81-100% of patients during a 
MDTM).
The follow-up often contained a GA without screening 
(76.2%). This might look overshooting, since it is 
recommended that a follow-up includes a geriatric screening 
followed by GA if necessary, in particular when the initial 
geriatric screening did not detect a geriatric risk profile at 
baseline (20-30% of patients (12)). In the current project 
of which this survey is a part no geriatric screening needs 
to be performed at follow-up, since the collection of GA 
results at follow-up are essential to evaluate the performance 
of geriatric recommendations and to define which geriatric 
recommendations need to be reconsidered. However, in 
practice conducting a screening at follow-up usually entails 
GA, since many older patients with cancer are hospitalized 
(e.g. chemotherapy administration, catheter implantation), 
start new medications (e.g. pain or symptom control) and/or 
experience therapy-related events (e.g. chemotherapy toxicity) 
with a possible impact on their GA domains. Eighteen hospitals 
(81.38%) reported follow-up completion for 81-100% of 
patients.
Information and communication technology (ICT) was 
frequently used to communicate geriatric screening and GA 
results. Undoubtedly, this is an important medium for fast 
communication (<24hours). However, fast communication 
might also be related to usage of more than one communication 
medium -which improves visibility of GA results. Further 
integration of GA elements in ICT might improve 
the quality of care, for example by assisting staff without 
specific geriatric training. This might prevent adverse events, 
functional deterioration, and cognitive decline (4). Further, 
ICT can lead to a common (geriatric) language within and 
between (networks of) healthcare organizations and might 
lead to clinical outcome measures and quality indicators 
(4). The InterRAITM tool is an example of a standardized 
communication system in transitional care, which has evolved 
from a classical GA, as currently used (4).
The complexity of implementing GA in daily oncology 
practice was reflected by the large number of categories that 
emerged from the free-text responses. A lot of barriers and 
facilitators only had a few responses, suggesting the importance 
of the local setting in which the GA was implemented (19). 
As found in two similar surveys regarding this topic, high 
workload, lack of time or financial/staffing problems is 
found to be the key barrier for implementing GA in daily 
oncology practice (9, 18). A shared strategy between healthcare 
professionals, teachers, managers, policy makers and 
researchers needs to be adopted in order to create additional 
time available that is convenient for the involved person(s). 
An important component within this strategy will undoubtedly 
be collaboration, cited as a paramount facilitator and barrier. 
Qualitative analysis revealed that collaboration includes GA 
specific and general components. Important elements within 
the general components were relevance of the GA concept and 
embedding GA in other geriatric care structures (e.g. geriatric 
day clinic, internal geriatric liaison). Reported affiliations of 
healthcare professionals, involved in the GA process, describe 
that already more than half of hospitals collaborate with the 
geriatric department for implementing GA in daily oncology 
practice. Further research is necessary to explore how cross-
fertilization between the geriatric and oncology department 
can be optimized, accounting for the possibility that other 
departments might need to collaborate as well since comorbid 
disease (heart failure, COPD, diabetes, cognitive disorders,…) 
are frequent in this population. The complexity of frail older 
persons does not only challenge clinicians, but also stimulates 
policy makers for rethinking care processes and financial 
structures. 
Quantitative and qualitative studies have shown that 
failure to implement evidence involves several factors at 
different levels of the healthcare system (11).  Therefore, the 
importance of less frequently cited facilitators and barriers on 
the implementation of GA in oncology practice may not be 
underestimated (19).
This study has some limitations that need to be considered 
when interpreting the results. The questionnaire was only 
completed by PI’s. Treating physicians, THCWs and 
geriatricians might address other factors influencing the 
implementation of GA in daily oncology practice.
The contribution of respondents varied a lot. Not all PI’s 
fully completed the open-ended questions. Some respondents 
described only 2 barriers instead of 3. Further, some answers 
were very extensive with several thematic categories, whereas 
others were very concise. Developing thematic categories from 
data includes attribution of an answer to a certain category. 
Although we tried to guarantee intercoder reliability and 
prevent researcher bias, individual interpretation is a potential 
limitation of any qualitative analysis (19). The coders did not 
contact respondents to verify data interpretation (20).
The results of this study are relevant and useful for clinical 
practice and further research. A strength of this study was the 
separate analysis of barriers and facilitators, since a barrier does 
not always equal the opposite of a facilitator (19).
Conclusion
The implementation of GA in older patients with cancer 
might be more feasible when initially started in a specific 
niche instead of all patients, although it remains recommended 
to approach the whole population. The number of geriatric 
recommendations implemented at baseline and follow-
up needs to be improved. Organizational characteristics and 
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collaboration play critical roles in the implementation of GA in 
older patients with cancer. All stakeholders, seeking to improve 
the implementation of GA in older patients with cancer, should 
consider and address the identified barriers and facilitators.
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